Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

5.410 -0.110 (-1.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 934,940
Open 5.590
Bid (Size) 5.140 (1)
Ask (Size) 7.990 (1)
Prev. Close 5.520
Today's Range 5.150 - 5.660
52wk Range 4.920 - 42.81
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Atreca (NASDAQ:BCEL) stock moved upwards by 43.1% to $2.39 during Friday's regular session. As of 12:30 EST, Atreca's stock is trading at a volume of 19.1... 
Via Benzinga
43 Stocks Moving In Friday's Mid-Day Session
Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after... 
Via Benzinga

Performance

YTD
-69.99%
-69.99%
1 Month
-15.86%
-15.86%
3 Month
-46.96%
-46.96%
6 Month
-72.69%
-72.69%
1 Year
-76.22%
-76.22%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Recursion Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
68 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities
Via Benzinga
Why Recursion Pharmaceuticals Stock Sank Today
Via The Motley Fool
Bet On Biopharma: Data, Digitization, Discovery
Via Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
68 Biggest Movers From Wednesday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
40 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
76 Biggest Movers From Yesterday
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2021
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.